Alfonso Ielasi, MD

Original Contribution

A High Dose of Adenosine to Induce Transient Asystole for Valvuloplasty in Patients Undergoing Transcatheter Aortic Valve Implantation (TAVI): Is it a Valid Alternative to Rapid Pacing? A Prospective Pilot Study

10/25/2011

Kensuke Takagi , MD;

Azeem Latib , MD, BCh, MBBCh;

Giedrius Davidavicius , MD;

Joanne Shannon , MD;

Francesco Arioli , MD;

Marco Mussardo , MD;

Francesco Maisano , MD;

Antonio Colombo , MD;

Alaide Chieffo , MD;

Matteo Montorfano , MD;

Alfonso Ielasi , MD;

Cosmo Godino , MD;

Abstract: Background. Rapid right ventricular pacing (RRVP) at rates above 200 beats/minute is used to suppress cardiac output during balloon aortic valvuloplasty (BAV) in transcatheter aortic valve replacement (TAVI) patients. A risk of...

Abstract: Background. Rapid...

10/25/2011

Journal of Invasive Cardiology

Original Contribution

One-Year Clinical Outcomes of Forty-Eight Millimeter Everolimus-Eluting Stent Implanted in Very Long Lesions: A Propensity-Matched Comparison (The FREIUS Study)

03/30/2018

Andrea Cuculo , MD;

Rossella Fattori , MD;

Pietro Sangiorgio , MD;

Rosario Parisi , MD;

Antonio Centola , MD;

Matteo Vercellino , MD;

Giovanni Longo , MD;

Gianfranco Pistis , MD;

Simone Biscaglia , MD;

Antonio Ruggiero , MD;

Paolo Nicola Marino , MD;

Gianluca Campo , MD;

Alfonso Ielasi , MD;

Carlo Di Mario , MD, PhD, FESC, FACC, FRCP;

Matteo Tebaldi , MD;

Gioel Gabrio Secco , MD;

The aim of our study was to evaluate the safety, feasibility, and cost effectiveness of a 48 mm everolimus-eluting stent (EES) during treatment of very long coronary lesions.

The aim of our study was to...

03/30/2018

Journal of Invasive Cardiology

Hard Events AfteR Orsiro Sirolimus-Eluting Stent (HEROES) in STEMI: A Multicenter Registry

12/01/2020

Vincenzo De Marzo , MD;

Marco Caruso , MD;

Domenico D'Amario , MD, PhD;

Gianmarco Annibali , MD;

Vincenzo Manganiello , MD;

Rocco Vergallo , MD, PhD;

Michael Donahue , MD;

Pio Cialdella , MD;

Alfonso Ielasi , MD;

Leonardo Misuraca , MD;

Bernardo Cortese , MD;

Luca Altamura , MD;

Italo Porto , MD, PhD;

Claudio Larosa , MD;

Rosario Parisi , MD;

Marco Canepa , MD, PhD;

Our objective was to evaluate the safety and efficacy of the Orsiro sirolimus-eluting stent (Biotronik) in patients with ST-segment elevation myocardial infarction undergoing primary PCI. Specific drug-eluting stent platforms might influence...

Our objective was to evaluate...

12/01/2020

Journal of Invasive Cardiology